Compare Mutual Funds
ITI Pharma and Healthcare Fund
Select a Mutual Fund
Risk
Very High
-
Rating
1.0
-
Min SIP Amount
₹500
-
Expense Ratio
2.69
-
NAV
₹19.44
-
Fund Started
18 Oct 2021
-
Fund Size
₹251.87 Cr
-
Exit Load
Exit load of 0.50%, if redeemed within 3 months.
-
1 Year
6.05%
-
3 Year
17.69%
-
5 Year
-
-
Equity
96.78%
-
Cash
3.22%
-
Top 10 Holdings
Sun Pharmaceutical Industries Ltd. | 13.34% |
Divi's Laboratories Ltd. | 6.79% |
Apollo Hospitals Enterprise Ltd. | 6.22% |
Dr. Reddy's Laboratories Ltd. | 5.44% |
Max Healthcare Institute Ltd. | 5.41% |
Cipla Ltd. | 4.60% |
Torrent Pharmaceuticals Ltd. | 4.56% |
Laurus Labs Ltd. | 4.40% |
Aurobindo Pharma Ltd. | 4.10% |
Lupin Ltd. | 3.30% |
-
Name
-
-
Start Date
-
-
Description
The scheme seeks to generate long term capital appreciation through investing in equity and equity related securities of companies engaged in Pharma and Healthcare.
-
Launch Date
18 Oct 2021
-
